SYNLOGIC, INC. (SYBX)
Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.
Address
PO BOX 30
WINCHESTER, MA 01890
Founded
2007
Number of Employees
6
Website
http://www.synlogictx.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | - | $2,518 | - | - | $2,518 |
| Average Price | - | - | - | - | - | - | - | - | $9.00 | - | - | $9.00 |
| # Shares Purchased | - | - | - | - | - | - | - | - | 279,793 | - | - | 279,793 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | -88.9% | - | - | -88.9% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | - | - | 37.3% |
| Excess Total Return | - | - | - | - | - | - | - | - | -126.2% | - | - | -126.2% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | 2% | - | - | 2% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at SYBX make a trade.
Creating a free account takes less than one minute